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Abstract46 
We previously identified genomic instability as a causative factor for vascular aging. In the 47 
present study determined which vascular aging outcomes are due to local endothelial DNA 48 
damage, which was accomplished by genetic removal of ERCC1 DNA repair in mice (EC-49 
KO mice). EC-KO showed a progressive decrease in microvascular dilation of the skin, 50 
increased microvascular leakage in the kidney, decreased lung perfusion, and increased aortic 51 
stiffness compared to WT. EC-KO showed expression of DNA damage and potential 52 
senescence marker p21 exclusively in the endothelium, as demonstrated in aorta. Also the 53 
kidney showed p21-positive cells. Vasodilator responses measured in organ baths were 54 
decreased in aorta, iliac and coronary artery EC-KO compared to WT, of which coronary 55 
artery was the earliest to be affected. Nitric oxide-mediated endothelium-dependent 56 
vasodilation was abolished in aorta and coronary artery, whereas endothelium-derived 57 
hyperpolarization and responses to exogenous nitric oxide were intact. EC-KO showed 58 
increased superoxide production compared to WT, as measured in lung tissue, rich in 59 
endothelial cells. Arterial systolic blood pressure was increased at 3 months, but normal at 5 60 
months, at which age cardiac output was decreased. Since no further signs of cardiac 61 
dysfunction were detected this decrease might be an adaptation to prevent an increase of 62 
blood pressure. In summary, a selective DNA repair defect in the endothelium produces 63 
features of age-related endothelial dysfunction, largely attributed to loss of endothelium-64 
derived nitric oxide. Increased superoxide generation might contribute to the observed 65 
changes affecting end organ perfusion, as demonstrated in kidney and lung.66 
67 
Key words: Aging, DNA damage, endothelium-dependent dilation, endothelial dysfunction, 68 
nitric oxide.69 
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Introduction75 
76 
Despite the currently available prevention and treatment options, cardiovascular diseases 77 
(CVD) continue to be a main cause of morbidity and mortality worldwide. Even when 78 
traditional risk factors are absent or controlled, cardiovascular problems remain a major health 79 
issue as reflected by the independent risk factor, age [1]. Aging, which is not synonymous to 80 
age, is a natural but very complex process leading to the decline and ensuing loss of organ 81 
function. The accumulation of DNA damage is considered as one of the primary causes driving 82 
the process of aging, and involves various processes [2,3]. Firstly, cells with unrepaired DNA 83 
damage may enter into apoptosis or senescence; apoptosis can lead to atrophy and organ 84 
function decline due to the loss of cells or tissue, and senescence-related mechanisms trigger 85 
the acquisition of a senescence-associated secretory phenotype (SASP) that affects surrounding 86 
cells and triggers age-related traits [4]. In parallel, accumulating DNA damage also triggers a87 
so-called ‘survival response’ that switches the organism’s physiological status from one that 88 
promotes growth to one that suppresses growth and focuses on maintenance of cellular 89 
homeostasis and function [5]. In humans, the presence of individual genetic and environmental 90 
variations evoke differences in the rate of aging between individuals, but also between organs 91 
within an individual. This differential pace of aging is also observed in mouse models of 92 
accelerated aging as provoked by DNA repair defects [5].93 
Several mouse models have been generated that, by deficiency of specific repair pathways,94 
show striking similarities to human aging [5]. One of these models is the Ercc1ǻí mouse. The 95 
ǻ allele is a truncation of the ERCC1 (Excision Repair Cross Complementation group 1) 96 
protein by 7 amino acids of its C-terminus [6]. This results in a hypomorph mutation, that 97 
largely (but not completely) abolishes its interaction with the XPF protein. ERCC1-XPF forms 98 
a heterodimic structure-specific endonuclease that incises the damaged strand at some distance 99 
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5’of the lesion [7]7KHǻDOOHOHKDVDSSUR[LPDWHO\UHVLGXDODFWLYLW\, causing impaired100 
function of the protein, progressive accumulation of DNA damage and numerous features of 101 
accelerated ageing, which are strongly delayed by dietary restriction, the only universal anti-102 
aging intervention [8].103 
ERCC1 is an essential component in the pathway of DNA nucleotide excision repair (NER), 104 
which removes a wide class of helix-distorting DNA lesions induced by UV, chemicals and 105 
oxidative stress. Apart from that, ERCC1 is involved in other DNA repair systems such as 106 
double strand break and cross link repair [9].  Mutations in proteins of the NER pathway have 107 
shown severe effects on human health as evidenced in several human progeroid syndromes 108 
such as Cockayne syndrome, trichothiodystrophy and Xpf-Ercc1 syndrome [7,10].109 
Ercc1ǻí mice are short-lived (24-28 weeks) and within 12 weeks from birth develop 110 
neurodegeneration, osteoporosis, many features of aging in liver, kidney, heart, muscle and the 111 
hematopoietic system. In 8-week old Ercc1ǻímice an increased blood pressure was observed, 112 
which appeared to become less apparent at 12 weeks of age [11,12]. Thus, the blood pressure 113 
increase might be biphasic. Also, increased vascular stiffness and loss of macro- and 114 
microvascular dilator function were observed [11]. The vasodilator dysfunction in Ercc1ǻí115 
mice is explained by reduced NO-cGMP signaling, partly due to decreased endothelial nitric 116 
oxide synthase (eNOS) expression [11]. Many of these features are very similar to what was 117 
previously found in normal rodent and human aging.118 
Segmental progeria observed in Ercc1 ǻímice implies that affected organs might be influenced 119 
by the impact of local and/or systemic DNA damage, processes associated with oxidative 120 
stress. To address the question if a local endothelial DNA repair defect is critical for the specific 121 
changes in vascular function as observed in Ercc1ǻí mice, we investigated cardiovascular 122 
function in a mouse model with specific loss of Ercc1 in vascular endothelial cells.123 
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Methods124 
Animals 125 
We evaluated the effect of endothelial genomic instability on cardiovascular function in a 126 
mouse model with endothelium-specific deletion of Ercc1 (Tie2Cre+ Ercc1fl/- mouse model). 127 
To target the endothelium, various Cre recombinase models are available. Tie2Cre models have 128 
been used most widely. VE-Cadherin- (CD144) Cre models have been suggested as being 129 
perhaps the models in which the endothelium is targeted most uniformly [13]. However, the 130 
only example known to us in which a direct comparison is made between the models does not 131 
reveal a difference, at least, when used for fate mapping purposes of EC in adult organs [14].132 
Both Tie2 and VE-Cadherin are not only expressed in endothelial cells, but also in 133 
hematopoietic (stem) cells (HSC), potentially affecting leucocyte populations of HSC-derived 134 
lineage [15-18]. Interestingly, Tie2 is known to be expressed in lineages forming monocytes 135 
that have a pro-angiogenic function [17]. Thus, leucocytes specifically devoted to endothelial 136 
maintenance would be undermined, possibly preventing also the recovery of the endothelium 137 
if Ercc1 deletion indeed leads to dysfunction of the mature endothelium. Therefore, we 138 
preferred the Tie2 promotor region as the sequence driving Cre-recombinase. To explore the 139 
consequences of Tie2Cre-driven Ercc1 deletion in HSC we have examined the blood of the 140 
relevant mouse strains (see below). 141 
The Cre-loxP system was used to generate a conditional mouse model expressing Cre-142 
recombinase under the control of the vascular endothelial cell receptor tyrosine kinase (Tie2)143 
promoter (Tie2Cre). Tie2Cre+/- female mice were crossed with Ercc1+/- male mice to generate 144 
Tie2Cre+/- Ercc1+/- mice in a pure C57BL/6J background. The females were then crossed with 145 
Ercc1fl/fl male mice in a pure FVB/N background to produce Tie2Cre+ Ercc1fl/- mice in a 146 
C57BL6/FVB F1 hybrid background [19]. These Tie2Cre+ Ercc1fl/- mice were homozygous 147 
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for Ercc1, after deletion of the floxed allele in endothelial cells expressing Cre-recombinase. 148 
These mice are referred throughout this manuscript as endothelial cell-knock out mice (EC-149 
KO). Littermates (genotypes: Tie2Cre+ Ercc1fl/+, Tie2Cre- Ercc1fl/+, Tie2Cre- Ercc1fl/-) were 150 
used as controls. All control mouse genotypes were combined and are referred to as WT mice 151 
in the paper. In order to test for potential differences between control genotypes, we performed 152 
some analyses separating the Cre+ Ercc1f/+ mice. For reactive hyperemia, ex vivo vascular 153 
function and mechanical properties of the carotid, we analyzed Cre+ Ercc1f/+ mice as a separate 154 
group. Mice were kept in individually ventilated cages, in a 12 h light/dark cycle and fed normal 155 
chow and water ad libitum.156 
EC-KO mice unexpectedly died at the age of 5.5 – 6 months (100% of the cases). Consequently, 157 
we decided to evaluate mice at 3 and 5 months of age. Mice under profound anaesthesia were 158 
euthanized by exsanguination from the vena porta. All animal procedures were performed at 159 
the Erasmus MC facility for animal experiments following the guidelines from Directive 160 
2010/63/EU of the European Parliament on the protection of animals used for scientific 161 
purposes. All animal studies were approved by the Animal Care Committee of Erasmus 162 
University Medical Center Rotterdam (protocol number 118-13-03).163 
Pathological examination, tissue collection and blood analysis164 
All sudden deaths of EC-KO occurred at night, except for two cases. One of these two mice165 
was submitted to whole body fixation in formalin for 48 hours and pathological examination.166 
Tissues were processed by paraffin-embedding techniques, sectioned, and stained with 167 
Hematoxylin and Eosin. Slides were examined by a board-certified veterinary pathologist. For 168 
mice sacrificed at 3 and 5 months of age, blood was collected under anesthesia from the vena 169 
porta and analyzed for cell counts. Vascular, cardiac, renal and lung tissue were collected for 170 
further study. For scanning electron microscopy (EM) abdominal aorta was fixed in 4% 171 
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formaldehyde / 2% glutaraldehyde. The lumen was exposed after longitudinal opening of the 172 
aorta, and scanning EM recordings were made after platinum sputtering.173 
Blood vessel permeability174 
We performed Evans Blue dye method in mice, as described [20], to determine the presence of 175 
vascular leakage in kidneys. In brief, we injected 100 uL of 1% Evans Blue dye (0.133 gr of 176 
Evans Blue in 10 ml of PBS with Ca2+ and Mg2+, prepared under sterile conditions) through 177 
femoral cannulation. After 4 hours of incubation, blood was drawn (100-200ul). Blood 178 
sampling was followed by whole animal PBS perfusion through the femoral infusion cannula 179 
after opening of the right atrium. Perfusion was performed with a peristaltic rotation pump until 180 
no blood residue remained in the atrium. Kidneys were collected, weighted and transferred to 181 
sample tubes with 500 μl of formamide. The sample tubes were incubated in a heat block at 182 
55°C for 24 hours to extract Evans Blue from the tissue. After incubation, the formamide/Evans183 
Blue mixture was centrifuged to pellet any remaining tissue fragments. Absorbance of each 184 
sample was measured at 610 nm (VersaMax™ Microplate Reader). Absorbance values from a 185 
standard curve with known concentrations of Evans Blue in formamide, with pure formamide 186 
as a background blank, and the total weight of each sample, were used to calculate the amount 187 
of Evans Blue per mg of renal tissue.188 
Cardiac function189 
Cardiac geometry and function were measured by performing 2-D guided short axis M-mode 190 
transthoracic echocardiography (Vevo770 High-Resolution Imaging System, VisualSonics) 191 
equipped with a 35-MHz probe. Left ventricular (LV) external and internal diameters were 192 
traced, and heart rate, LV mass and fractional shortening were subsequently calculated using 193 
the VisualSonics Cardiac Measurements Package. Mice were anesthetized with 2,5% and 194 
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maintained with 2,0% isoflurane, the animals were breathing freely and intubation was not 195 
required, while body temperature was kept at 37°C. 196 
Blood pressure measurement197 
Blood pressure (BP) was measured non-invasively in conscious mice using the tail cuff 198 
technique (CODA High-Throughput device, Kent Scientific). BP was measured on 5 199 
consecutive days and each session consisted of 30 measurement cycles for each mouse. The 200 
first 4 days were taken as acclimatization sessions. BP values reported here correspond to the 201 
average of all valid measurements recorded at day 5. 202 
In vivo aortic strain203 
Using the data on systolic and diastolic aortic diameters acquired by transthoracic 204 
echocardiography, we calculated aortic strain by subtracting the diastolic aortic diameter from 205 
the systolic aortic diameter. 206 
Microvascular vasodilator function and lung perfusion in vivo207 
We assessed in vivo vasodilator function using Laser Doppler perfusion imaging, after three to 208 
seven days of blood pressure measurement. Reactive hyperemia, defined as the increase of the 209 
hindleg perfusion after temporary occlusion of the blood flow, was calculated. Blood flow was 210 
measured in the left hindleg one day after removing the leg’s hair using a hair removal cream. 211 
The hindleg was kept still with help of a fixation device. After recording baseline perfusion for 212 
5 minutes, blood flow was occluded for 2 minutes with a tourniquet. To record hyperemia and 213 
the return of the blood flow to the post-occlusion baseline, blood flow was monitored for 10 214 
minutes after releasing the tourniquet. During all measurements mice were under 2.8% 215 
isoflurane anesthesia, and temperature was constantly monitored and maintained between 36.4-216 
37.0 °C. For each mouse we calculated the maximum response to occlusion and the area under 217 
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the curve relative to the post-occlusion baseline. Only the area above the baseline was 218 
considered. Values below the baseline were set at 0.219 
In a separate set of 5 month-old WT vs. EC-KO (n= 4 vs 7), lung perfusion was measured by 220 
microCT imaging. μCT scans were performed and reconstructed at the Applied Molecular 221 
Imaging Erasmus MC facility (AMIEf) by using the Quantum FX (PerkinElmer). Mice were 222 
anesthetized with 2.5% isoflurane in O2 and received an IV injection with eXIA160 (Binitio 223 
Biomedical Inc., Canada) contrast agent. The injected amount of agent followed the dose 224 
recommended by the manufacturers. First, a pre-contrast scan was made as a baseline. The 225 
animal was taped to the imaging bed with a catheter placed in the tail vein to ensure minimal 226 
displacement and prevent misalignment during post-processing. After acquisition of the pre-227 
contrast scan, the contrast agent was slowly infused (150-200 uL in 1 minute), after which a 228 
second scan was made. Mice were scanned using intrinsic cardio-respiratory gating to reduce 229 
artifacts caused by breathing. CT acquisition parameters: 90kv, 160μA, field of view 20mm, 230 
40 um resolution with an acquisition time of 4,5 min. Scans were quantified using Analyze 231 
11.0 software (AnalyzeDirect). By using the image calculator option the pre-contrast image 232 
was subtracted from the post-contrast image. This resulted into an image of iodine only, which233 
was subjected to further filtering with a median filter (kernel size 3 x 3 x 3). During semi-234 
automatic segmentation of the lungs, the large and midsize blood vessels were excluded. On 235 
the resulting lung image segmentation, we calculated the average intensity value as a measure 236 
for average lung perfusion, with a minimum of 40% of total lung volume. 237 
Ex vivo vascular functional assessment238 
239 
Immediately after sacrifice thoracic aorta, iliac and left anterior descending coronary arteries 240 
were carefully dissected from mice and kept in cold Krebs-Henseleit buffer (in mmol/L: NaCl 241 
118, KCl 4.7,CaCl2 2.5, MgSO4 1.2 , KH2PO4 1.2, NaHCO3 25 and glucose 8.3 in distilled 242 
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water; pH 7.4). Vessel rings of 1.5-2 mm length were mounted in small wire myograph organ 243 
baths (Danish Myograph Technology, Aarhus, Denmark) containing 6 mL of Krebs-Henseleit 244 
buffer oxygenated with 95% O2 and 5% CO2. After warming, the tension was normalized by 245 
stretching the vessels in steps until 90% of the estimated diameter at which the effective 246 
transmural pressure of 100 mmHg is reached. Thereafter, the viability of the vessels was tested 247 
by inducing contractions with 30 and 100 mmol/L KCl. After the maximum response to KCl 248 
had been reached vessels were washed. To evaluate vasodilatory responses, aortic and iliac 249 
segments were first pre-constricted with 30 nmol/L of the thromboxane A2 analogue U46619, 250 
resulting in a preconstriction corresponding with 50-100% of the response to 100 mmol/L KCl. 251 
After this, concentration-response curves (CRCs) were constructed with the endothelium-252 
dependent vasodilator acetylcholine (ACh) at cumulative doses (10-10-10-5 mol/L). When the 253 
CRC to ACh was completed, we used the endothelium-independent vasodilator sodium 254 
nitroprusside (SNP, 10-4 mol/L). Complete CRCs to SNP (10-10-10-4 mol/L) were performed in 255 
parallel rings preconstricted with 30 nmol/L U46619.256 
The contribution of nitric oxide (NO) and prostaglandins in the aortic ACh responses was 257 
explored by performing the experiments in the presence of the nitric oxide synthase inhibitor 258 
NG-nitro-L-arginine methyl ester salt (L-NAME, 10-4 mol/L) and the cyclo-oxygenase (COX) 259 
inhibitor indomethacin (INDO, 10-5 mol/L). Inhibitors were added to the organ bath 20 260 
minutes prior to U46619. 261 
To assess the potential involvement of ROS in the blunted vasodilator response to ACh, we 262 
used N-acetyl-cysteine (NAC; 10-2 mol/L), which is an aminothiol and synthetic precursor of 263 
intracellular cysteine and GSH and a non-specific ROS scavenger [21]. Moreover to 264 
determine whether altered vasodilation involves hydrogen peroxide, we used PEG-catalase265 
(PEG-CAT; 0.01 mg/ul), which catalyzes the decomposition of hydrogen peroxide to water 266 
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and O2. Vessels were pre-treated with NAC or PEG-CAT for 1h prior to the ACh dose 267 
response curve.268 
In coronary arteries we investigated endothelium-dependent vasodilation by performing CRCs 269 
to ACh and to the Adenosine 5'-O-(2-WKLRGLSKRVSKDWH $'3ȕ6 DQG 8ULGLQH- 5'- O- (3-270 
WKLRWULSKRVSKDWH873Ȗ67KHLQWUDFHOOXODUVLJQDOOLQJDFWLYDWLRQFDXVHGE\$'3DQG873271 
has not been studied in detail in the mouse heart. However, studies on blood pressure and 272 
cerebral arterioles in the eNOS-/- mice have shown that the two nucleotides do not cause 273 
vasodilation through the same mechanisms. It is thought that UTP-induced vasodilation 274 
exclusively involves endothelium-dependent hyperpolarization (EDH) [22], while ADP acts 275 
through both NO and EDH on a 50%/50% basis.[23] &5&V WR $'3ȕ6 DQG 873Ȗ6 ZHUH276 
performed in coronary arteries precontracted with U46619 and then in coronary segments 277 
precontracted with 30 mM KCl. The latter was done to elucidate the contribution of EDH in 278 
$'3ȕ6- DQG873Ȗ6-induced vasodilation because when arteries are precontracted with 30 279 
mmol/L KCl, EDH cannot occur because the artery is too strongly depolarized.[24-26] VSMC 280 
dilatory function was tested by constructing CRCs to the NO donor SNP. 281 
In iliac rings, after washing out KCl 100 mmol/L, we investigated contractile responses to 282 
angiotensin II (Ang II, 10-10-10-7 mol/L), endothelin-1 (ET-1 10-10-10-6 mol/L) and 283 
phenylephrine (PE, 10-9-10-5 mol/L). For detailed information see Supplementary Methods.284 
Mechanical properties and dimensions of the vascular wall285 
Carotid arteries explanted from 5 months old mice were mounted in a pressure myograph 286 
(Danish Myograph Technology (DMT), Aarhus, Denmark) in calcium free buffer (in mmol/L: 287 
NaCl 120, KCl 5.9, EGTA 2, MgCl2 3.6, NaH2PO4 1.2, glucose 11.4, NaHCO3 26.3; pH 7.4). 288 
The intraluminal pressure of the carotid artery was increased stepwise by 10 mm Hg starting 289 
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at 0 mm Hg and reaching 120 mm Hg. Lumen and vessel diameter were measured and used to 290 
calculate wall strain and stress [27].291 
Mechanical properties of the aortic wall were tested in a protocol that was earlier described by292 
Fleenor and colleagues [28]. In short, aortic segments of 1.5 to 2.0 mm length were hung in 293 
small wire organ baths filled with Ca2+-free buffer with clamps just touching each other (zero 294 
position). After 1 hour of acclimatization the rings were pre-stretched 3 times for 3 minutes to 295 
1 mm separation of the clamps from the zero position. After returning again to the zero position,296 
the rings were set to a pretension of 1 mN by moving the clamps apart. The strain at this 297 
distance of the 2 clamps was set at “1”. A series of 10% increasing strain values was created 298 
by stepwise increase of the clamp distance, with 3 minutes pauses between each step for 299 
equilibration. Thus, a series of 1, 1.1, 1.2, … , 2.5 was constructed. The wires were not able to 300 
withstand more tension without bending. Burst point was not reached. Thus, applying this 301 
method we were able to measure mechanical properties of the aortic wall in the force range 302 
representing the plasticity observed in the physiological blood pressure range (80 – 120 mmHg; 303 
strain of 1.5 to 2.0, as determined with DMT normalization software), and beyond. For the 304 
force developed at each strain Ȝ of unidirectional displacement, stress (S) was calculated 305 
applying the formula 6 Ȝ)+/with F = developed force in mN, T = wall thickness, L306 
=length of vessel segment. Wall thickness and other variables presented herein were measured 307 
by light microscopy, using calibrated Leica QWin software (Germany), at 50x magnification 308 
in 10 μm, eosin-stained cryo-sections made from separately isolated aortic tissue of the area 309 
adjacent to the segment tested in the organ bath. 6 EC-KO vs. 7 WT were tested of which 1 310 
WT was a statistical outlier for stress at strain 2.4, 1 WT stiffness measurement failed due to 311 
technical problems with the organ bath set up. Only sections of segments that formed a 312 
complete vessel wall and that were, by approximation, circular were included for measurement 313 
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of vessel diameter and circumference, explaining the lower n in EC-KO for these 314 
measurements.315 
Quantitative real-time PCR316 
Total RNA was isolated from aortic tissue and cDNA was prepared, which was amplified by 317 
real-time PCR on a StepOne thermocycler (Applied Biosystems). Each reaction was performed 318 
LQGXSOLFDWHZLWK6<%5*UHHQ3&50DVWHU0L[$SSOLHG%LRV\VWHPVȕ-actin and HPRT-1319 
were used for normalization. The relative amount of genomic DNA in DNA samples was 320 
determined as follows: RQ = 2(-¨¨&W. Sequences of the primers used are provided in 321 
supplementary Table S1.322 
Immunoblots and immune histology323 
Frozen tissues were homogenized in ice cold RIPA buffer (50 mmol/L HCl pH 7.4, 150 324 
mmol/L NaCl, 1% NP-40, 0.25% Na-deoxycholate and 1 mmol/L EDTA) containing protease 325 
and phosphatase inhibitors (1 mmol/L PMSF, 1 mmol/L NaVO4 PPRO/1D)ȝJP/326 
aprotiniQ  ȝJP/ SHSVWDWLQ DQG  ȝJP/ OHXSHSWLQ XVLQJ D VWDLQOHVV-steel ultraturrax 327 
(Polytron). Homogenized tissues were centrifuged and protein concentration was measured in 328 
the supernatants using the BCA method (Thermo Scientific, USA). Membranes were blocked329 
with 3 - 5% milk or 5 % BSA in TBS-T. After blocking, membranes were incubated overnight 330 
with the primary antibodies as follows: eNOS (Santa Cruz, SC-654 1:500 in 5% milk TBS-T),331 
pSer1177- eNOS (Santa Cruz, SC-21871-R 1:500 in 5% BSA TBS-T), and Ercc1 (Abcam, 332 
Ab129267, 1:1000). We used an HRP (Horseradish peroxidase) - conjugated antibody (Bio-333 
Rad 1:2000 in 1% milk-TBS-T) to detect the primary antibodies. For visualization we used an 334 
enhanced chemiluminiscent substrate for detection of HRP (Pierce ECL Immuno-Blotting 335 
Substrate, Thermo Scientific). Expression levels of eNOS and Ercc1were normalized to actin336 
and cofilin. Lung protein of an Ercc1-/- full body knockout mouse was used as a negative control 337 
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for background subtraction.338 
For immunohistochemical stainings, aortic and kidney tissue were fixed in 4% buffered 339 
formaldehyde for 24 KUVHPEHGGHGLQSDUDIILQDQGVHFWLRQHGDWȝP$IWHUGHSDUDIILQL]DWLRQ340 
and rehydration, all sections were incubated in antigen retrieval buffer (pH9) for 15 min at 341 
100°C. Endogenous peroxidase was blocked by incubating the sections in 3% H2O2 in 342 
methanol for 10 min. For immunohistochemical staining the slides were blocked for 1 hr and 343 
stained with P21 (1:100 ab107099) overnight at 4°C. Sections were incubated for 1hr at room 344 
temperature with the corresponding biotinylated secondary antibody (1:200 Vector BA-9400345 
and Dako E0432). After ABC (Vectastain PK-6100) incubation of 30 minutes, sections were 346 
subjected to DAB staining (Dako K3468). Images were acquired using Nanozoomer software 347 
and analyzed with NDP view 2. 348 
ROS, H2O2, and superoxide measurement349 
Various markers of oxidative stress were assessed as previously described [29,30]. Briefly,350 
superoxide anion (O2-) production was measured in lung tissues (rich in endothelial cells) by351 
lucigenin chemiluminescence assay. This assay uses NADPH as the substrate and 352 
accordingly the chemiluminescence signal reflects NADPH-dependent O2- generation and is a 353 
measure of NADPH oxidase (Nox) activity. Nox is a major source of ROS in vascular cells. 354 
Hydrogen peroxide (H2O2) levels were measured by Amplex Red assay. Global O2- levels in 355 
cell homogenate were measured by electron paramagnetic resonance (EPR) in samples 356 
containing 10 ug of protein and 1mM CMH (Enzo Life Sciences, UK) in a total volume of 357 
100 ul of Krebs-HEPES buffer containing 25uM deferoximine and 5uM 358 
diethyldithiocarbamate (DETC). After homogenization, EPR samples were placed in 50μl 359 
glass capillaries and measurements were performed by Bruker BioSpin’s e-scan EPR 360 
(Bruker® Biospin Corp.) equipped with a super-high Q microwave cavity at room 361 
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temperature. The EPR instrument settings for experiments were as follows: field sweep, 50 362 
G; microwave frequency, 9.78 GHz; microwave power, 20 mW; modulation amplitude, 2 G; 363 
conversion time, 656 ms; time constant, 656 ms; 512 points resolution and receiver gain, 364 
1×105. Results were normalized by protein content.365 
Statistical methods 366 
Data are presented as mean and standard error of the mean, unless otherwise indicated.367 
Statistical analysis between the groups of single values was performed by unpaired, two-tailed368 
t-test. Differences in dose-response curves were tested by general linear model for repeated 369 
measures (sphericity assumed). Differences were considered significant at p <0.05.370 
371 
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Results372 
General health features373 
There were no general signs of developmental problems in EC-KO, and body weight was 374 
normal up until 5 months of age (Figure 1A). Blood cell analyses revealed no significant 375 
changes (supplementary Table S2). However, EC-KO had a strongly reduced lifespan, with a 376 
median of 24.6 weeks (supplementary Figure S1). Shortly before death, immobility and rapid 377 
breathing was observed in 2 of the EC-KO mice. Most deaths occurred at night. One of the two 378 
moribund mice, aged 22.6 weeks, was timely sacrificed to undergo full body pathological 379 
examination. Organs included were brain, heart, skeletal muscle, aorta, sciatic nerve, liver, 380 
spleen, lung and kidney. Again, no signs of developmental problems were observed. Except 381 
for necrosis observed in the medulla of the kidney, the examined organs did not show 382 
morphological or histological aberrations. In 3 out of 5 EC-KO vs. 1 out of 6 WT of 5 months 383 
of age the kidney revealed red blood cells in the tubules (Figure 1B-C), indicating 384 
microvascular leakage in EC-KO. These data suggest that endothelial DNA repair deficiency385 
impairs the permeability of the renal medullary microvasculature.386 
Renal vascular permeability387 
To corroborate the increased permeability of the renal vasculature we used an in vivo Evans 388 
Blue tissue penetration assay, comparing the vessel leakage between EC-KO and WT mice (5389 
months old mice) in kidneys. The difference in vessel permeability was quantified 390 
spectrophotometrically by measuring the Evans Blue that was captured per gram of tissue. Our 391 
results show an increase in dye leakage from the kidney vessels of EC-KO mice when 392 
compared with WT mice (Figure 1D, p-value=0.05).393 
394 
In vivo microvascular function395 
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To further examine peripheral microvascular function we performed laser Doppler reactive 396 
hyperemia studies. At 3 months of age there was no difference in reactive hyperemia in the 397 
hindlimb skin between EC-KO and WT (Figure 2A, B, E, F). At 5 months EC-KO showed398 
decreased reactive hyperemia (Figures 2C-F). When passing from the age of 3 to 5 months 399 
reactive hyperemia tended to increase in WT mice, whereas it tended to decrease in EC-KO400 
mice. In addition, lung perfusion was measured in WT (n=4) and EC-KO mice (n=7) showing 401 
significantly decreased lung perfusion in EC-KO mice (Figure 3A-C). The evaluation of 402 
reactive hyperemia in the WT group showed no differences between Cre+ Ercc1f/+  and the other 403 
control genotypes.404 
Ex vivo vasodilator responses in aorta and iliac arteries 405 
To examine vasodilation in large arteries and reveal the mechanism of vasodilator dysfunction 406 
ex vivo organ bath experiments were performed. Aorta and iliac artery of EC-KO showed 407 
decreased endothelium-dependent relaxations to acetylcholine compared to WT at the age of 5 408 
months, which were still absent at 3 months of age (Figure 4A, B). Vascular smooth muscle 409 
dilatory function to the NO donor SNP was intact at both ages (Figure 4C-D). In WT mice, 410 
approximately half of the ACh response was mediated by NO (response to ACh was reduced 411 
by ~50% in the presence of the eNOS inhibitor L-NAME) (Figure 5A). No apparent 412 
contribution of prostaglandins was observed since the COX inhibitor indomethacin did not 413 
further reduce vasodilator responses (Figure 5A). Compared to WT mice, in EC-KO there was 414 
no contribution of the NO or prostaglandin pathways to the ACh responses (Figure 5B). In both 415 
WT and EC-KO a residual ACh response was observed that was similar in both groups of mice,416 
suggesting that the contribution of endothelium-derived hyperpolarizing factors (EDHFs) is 417 
intact.418 
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We found no differences in the ex vivo vasodilatory responses between Cre+ Ercc1f/+  and the 419 
rest of genotypes in the WT group (not shown).420 
The reduced NO availability and vasodilator dysfunction EC-KO mice could be explained by421 
oxidative stress. NAC resulted in a leftward shift (pEC50 control -6.996 ± 0.1215 (n=9) vs. 422 
NAC -7.825 ± 0.2451 (n=10), p<0.05) of the ACh dose response in EC-KO mice (Figure423 
5C), but not in WT littermates. These findings suggest a role for ROS in impaired 424 
vasodilation in EC-KO. PEG-CAT had no effect on ACh responses in EC-KO (Figure 5D)425 
indicating that H2O2 is likely not important in altered vasodilation in these mice.426 
To further examine the role of oxidative stress we measured NADPH-dependent ROS 427 
generation -by lucigenin chemiluminescence, O2- levels by EPR and H2O2 by Amplex Red. 428 
This was done in lung tissue, which is relatively rich in endothelial cells, and which clearly 429 
shows reduced perfusion (Fig. 3A-C). O2- and H2O2 levels were not different between EC-430 
KO and WT (Supplementary Figure S2). However, NADPH-mediated O2- production, an 431 
index of NADPH oxidase (Nox) activity, was significantly elevated in EC-KO compared to 432 
WT mice (Figure 5E).433 
Ex vivo vasodilator responses in coronary arteries 434 
As a representative for mid-sized arteries important for direct blood supply in vital organs 435 
relevant for cardiovascular disease we examined coronary artery function. In coronary arteries 436 
endothelium-dependent relaxation to ACh was significantly decreased in EC-KO both at 3 437 
months and 5 months of age (Figure 6A, p-value=0.009 and 0.0007, respectively).438 
Endothelium-independent relaxations to SNP were unchanged (Figure 6B). To study other 439 
endothelium-dependent agonists than ACh and the mechanism of vasodilator dysfunction 440 
$'3ȕ6(NO and EDH-dependent) DQG873Ȗ6(EDH-dependent) were employed. 441 
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ADPȕ6 relaxation curves were shifted rightward in EC-KO (Figure 6C, p-value=0.03) but 442 
responses to UTPȖ6 unchanged (Figure 6D). Responses to ADPȕ6 and UTPȖ6 in arteries 443 
preconstricted with 30 mmol/L KCl were examined as to exclude EDH [24-26]. Maximal 444 
dilations WR$'3ȕ6were decreased in EC-KO vs. WT (Figure 6E), whereas dilations to873Ȗ6445 
were cancelled in both mouse strains (Figure 6F). This result confirms that UTPȖ6 is entirely 446 
dependent on EDH, and that NO-mediated responses are decreased in EC-KO.447 
Levels of eNOS, luminal endothelial coverage, and Ercc1 expression448 
Immunoblot analysis showed a tendency towards reduced baseline pulmonary eNOS protein 449 
level in EC-KO vs. WT, but this did not reach statistical significance (Figure 7A). Also, the 450 
ratio of eNOS-activating phosphorylation of the serine residue at position 1177 (pSer1177-451 
eNOS) to total eNOS protein was not different at baseline (Figure 7A). The luminal surface of 452 
the abdominal aorta from 5 months-old animals was investigated for endothelial denudation (5 453 
WT vs. 5 EC-KO). Scanning EM of the luminal surface also did not reveal a loss of endothelial 454 
cells (Figure 7B). ERCC1 protein expression of the conditional Ercc1 KO allele was tested in 455 
homogenized lung tissue as a surrogate for endothelial knockout. ERCC1 protein was 456 
significantly lowered in 5 months old EC-KO (n=4) compared to WT (n=4) (Figure 7C). 457 
Ex vivo vasoconstrictor responses458 
We tested contraction responses in iliac arteries to ET-1, Ang II and phenylephrine 459 
(supplementary Figure S3). Although at the age of 5 months phenylephrine responses were 460 
significantly lower in EC-KO, implying an effect of endothelial dysfunction on VSMC, we saw 461 
no consistent differences between WT and EC-KO of 3 and 5 months of age.462 
463 
Mechanical properties and dimensions of the vascular wall464 
Since we previously found that arterial stiffness was increased in Ercc1ǻ- mice,[11] we 465 
measured aortic wall movement during cardiothoracic echography, and calculated 466 
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distensibility of the aorta. At 3 months no differences were found between EC-KO and WT but 467 
at 5 months distensibility was decreased in EC-KO despite normal pulse pressures (Table 1).468 
Since echography was not accompanied by simultaneous blood pressure measurements, which 469 
are needed for indexation of aortic distensibility, we further evaluated the mechanical 470 
properties of aortic rings in organ baths. We confirmed that aorta of EC-KO was stiffer than 471 
that of WT (Figure 5F). Instead carotid arteries did not show significant differences in stiffness,472 
lumen diameter or wall thickness under similar perfusion pressure increments between EC-KO473 
and WT. Likewise, no differences in media strain or stress were observed (supplementary 474 
Figure S4).475 
To determine if the higher stiffness of aorta was associated with structural remodelling, the 476 
dimensions of transversally sectioned aortic segments were measured. This was done in 477 
sections taken from the part adjacent to the segment used for stiffness measurement. Wall 478 
thickness was not significantly increased (Figure 8A). Vascular diameter showed a trend to be 479 
increased in EC-KO, being statistically significant for external diameter (Figure 8B,C). 480 
Transversal surface area was higher in EC-KO than in WT aorta (Figure 8D). Vessel 481 
circumference also increased, showing a significant increase in external circumference (Figure 482 
8 E,F). Hence, EC-KO showed a hypertrophic aorta wall featured by outward remodelling.483 
Blood pressure484 
Systolic blood pressure (SBP) was higher in EC-KO at 3 months (138 mm Hg in EC-KO vs 485 
125 mm Hg in WT mice) whereas no differences were observed at 5 months (p-value 486 
SBP=0.72). No differences were observed in diastolic blood pressure (DBP) at 3 or 5 months 487 
(Table 1).488 
Cardiac function489 
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The change in SBP followed a biphasic course, being slightly elevated at 3 months and returned 490 
to normal at a time when endothelium-dependent vasodilation was markedly reduced (5 491 
months). Therefore, we investigated cardiac function, measuring volume variables, as a 492 
possible explanation. Since male and female mice have a different heart volume and weight, 493 
both two-way ANOVA including genotype and sex, were used as statistical corrections for 494 
these variables. No differences between EC-KO and WT were observed at 3 months. However, 495 
stroke volume (SV) and cardiac output (CO) were significantly decreased in 5 month-old EC-496 
KO compared to WT (Table 1). In agreement, SV and CO indexed for heart weight were also 497 
decreased. When indexed for body weight however, SV and CO were equal between EC-KO 498 
and WT (Table 1). To exclude a sex-specific effect of Ercc1 knockout we analysed males and 499 
females separately, and found that that CO and SV were lowered in EC-KO for both sexes 500 
(data not shown). Indexed CO and SV were unchanged per sex. Given that FS and HW were 501 
normal we conclude that there was no cardiac dysfunction. However, since non-indexed and 502 
heart weight-indexed CO and SV were significantly or borderline significantly (p=0.06) 503 
lowered, we cannot rule out that cardiac function adapted to decrease the blood pressure at 5 504 
months of age.505 
Endothelial DNA damage response506 
To study if Tie2Cre-driven Ercc1 removal leads to an endothelial DNA damage response we 507 
performed immunohistochemistry on the damage response marker p21, a marker that is 508 
associated with cellular senescence, in aorta. We stained 4 randomly taken sections of thoracic 509 
aorta per mouse, using 5 mice per genotype (EC-KO or WT littermate). Controls incubated 510 
with secondary antibody alone were negative (not shown). When incubated with both primary 511 
and secondary antibody, we found that aortic sections in n=4 out of n=5 EC-KO contained 512 
scattered p21-positive endothelial cells (Figure 9A), whereas all WT mice (n=5) were devoid 513 
of positive cells (Figure 9B). There were no positive cells outside the endothelium, 514 
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demonstrating the specificity for vascular endothelial cells. Since leakage studies with Evans 515 
Blue revealed that the renal vasculature was also affected, we stained 4 randomly taken renal 516 
tissue section for p21 for each of n=5 mice. In 5 out of 5 EC-KO mice positive cells were517 
detected, scattered over glomeruli and in vascular lumen (Figure 9C,D), whereas WT (n=5) 518 
kidneys were all negative (Figure 9E). The localization of the positive cells along vascular 519 
lumen indicates that renal endothelial cells were affected. Since glomeruli consist largely of 520 
endothelium, it seems likely that the p21-positive cells are endothelial cells as well.521 
It is generally believed that dysfunction of endothelial cells during aging contributes to a pro-522 
inflammatory lamina media of the vessel wall, and thus to hypertrophic vascular remodeling.523 
We questioned if this occurs spontaneously in the absence of an exogenous pro-inflammatory 524 
stimulus, i.e. only by selective aging of endothelium. We tested expression of IL-Į,/-6, and 525 
71)Į mRNA. We chose these mediators because they are associated with the SASP, the 526 
secretory phenotype of senescent cells. We did not observe changes in aortic expression of IL-527 
Į,/-DQG71)Į (Supplementary Figure S5).528 
529 
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Discussion530 
We investigated the role of endothelial specific DNA repair defectiveness on cardiovascular 531 
function in a mouse model with specific loss of Ercc1 in vascular endothelial cells. We found 532 
that local endothelial genomic instability caused progressive macrovascular and microvascular 533 
vasodilator dysfunction at least in part due to specific loss of endothelium-derived NO. Smooth 534 
muscle responses to exogenously supplied NO were intact. Reduced eNOS expression does not 535 
seem to play a major role. The preserved endothelial cell layer, as confirmed by scanning EM 536 
as well as normal EDHF-mediated vasodilation, excludes the loss of NO through reduced EC 537 
numbers as a possible explanation. The most likely cause for the loss of vasodilation is reduced 538 
NO availability in EC-KO due to scavenging by ROS.  The blunted endothelium-mediated NO 539 
responses are associated specifically with expression of the DNA damage response, cell stress540 
and potential senescence marker p21. Thus, DNA damage results in a cell autonomous effect541 
on NO signaling that might drive vascular aging. The change of endothelial function appears 542 
to affect VSMC as well, as evidenced by altered vasoconstriction, increased aortic stiffness and 543 
aortic hypertrophic remodeling, important features of vascular aging. This appears to be 544 
independent of a pro-inflammatory phenotype of medial cells, because in EC-KO aorta mRNA 545 
expression of inflammatory mediators IL-DQG71)ĮLPSRUWDQWin vascular inflammation, 546 
was not increased. 547 
Notably, the rate of development of vasodilator dysfunction is location-specific as at 3 months 548 
of age this dysfunction is observed in coronary arteries, but not in iliac artery, aorta, or the skin 549 
microvasculature. This suggests a non-developmental origin of the vasomotor dysfunction.550 
Apart from location-specific effects with respect to the origin of the artery that was studied, we 551 
also found location-specific effects within the arterial specimen itself. The presence of p21 only 552 
in endothelial cells, and the absence of decreased VSMC responses to NO upon stimulation 553 
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with SNP suggests that a cell-autonomous effect is observed in EC-KO with regard to 554 
endothelium-derived NO. Previously, in the whole body Ercc1 knockout strain, Ercc1ǻ/- [11],555 
lowering of eNOS was observed in lung tissue. In endothelial cells eNOS might mediate cell-556 
autonomous effects. However, in EC-KO we only observed a statistically non-significant trend 557 
towards lowering of eNOS. It is known that eNOS reacts to aging in diverse ways, varying 558 
from increased expression to compensate for loss of vasodilator capacity due to NO scavenging 559 
by ROS in an early, compensated stage of endothelial aging, to decrease of eNOS and its 560 
activation in senescent cells [31-33]. The Cre-lox system does not remove the target gene with 561 
100% efficiency, and indeed not all endothelial cells in EC-KO are p21-positive. Moreover, 562 
not all p21-positive cells might be senescent; the presence of several markers in combination563 
is needed to confirm senescence. Therefore, it might be that there were senescent cells with 564 
lower eNOS, but not enough to statistically demonstrate eNOS lowering. Hence, the possibility 565 
that the observed lowering of ACh responses is the result of both NO quenching in the context 566 
of oxidative stress and eNOS lowering cannot be excluded.567 
Apart from vasodilator dysfunction EC-KO showed a severely compromised microvascular 568 
barrier function in the kidney. This was confirmed by histological examination and Evans Blue569 
permeability tests, established methods for this purpose [34]. Therefore, the aging-mimicking 570 
effect of endothelial Ercc1 deletion is not restricted to loss of vasodilator function, but at least 571 
affects barrier function in the kidney as well. Through this mechanism, the DNA damage 572 
response might contribute to progressive kidney damage, in addition to decreased NO 573 
signaling, an important determinant of renal deterioration [35]. Interestingly, cell cycle arrest 574 
in tubular cells induced by p21 plays a role in acute kidney injury (AKI), and plasma p21 levels575 
have been proposed as a biomarker for AKI and renal aging [36,37]. It was suggested that this 576 
might take place independently from DNA damage because of the dissociation of DNA damage 577 
detection through ATM signaling [36,38]. However, this only excludes double strand break 578 
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repair to be involved, although recently also transcription stress related R-loops were found to 579 
trigger ATM activation [39]. The question if DNA damage is involved therefore remains open. 580 
Our present finding prompts the question if endothelial aging, either caused by DNA damage 581 
or other mechanisms, might be implicated in p21-driven renal injury, and warrants further 582 
inspection of renal pathophysiology in endothelium-specific accelerated aging models.583 
In search of other features of vascular aging we tested vascular stiffness. At 5 months of age, 584 
aortic strain measured by echography was reduced in EC-KO, suggesting increased vascular 585 
stiffness. This was confirmed by ex vivo stress and strain measurements in aorta. The increased 586 
stiffness might be caused by the hypertrophic remodeling that we also observed in EC-KO. In 587 
contrast to aorta, carotid arteries did not show a change in vascular stiffness, again pointing to 588 
location-dependent difference. Increase of arterial stiffness with age, detected as increase of 589 
pulse wave velocity (PWV), is considered as a solid marker of vascular aging in humans [40].590 
PWV can be measured over different regions, such as from carotid to femoral, from brachial 591 
to carotid and from brachial to femoral artery. The different modes of PWV measurement show 592 
differential associations with age. Although this could involve technical aspects during 593 
measurements, it cannot excluded that differential rates of aging occur in diverse blood vessels.594 
This is well-known for plaque development. Internal mammary arteries, for example, are 595 
relatively resistant to atherosclerotic burden, which has been attributed to endothelial features596 
[41]. Coronary artery and aorta are generally known to be more vulnerable to plaque 597 
development. It is tempting to speculate that a differential susceptibility of the endothelium to 598 
DNA damage contributes to these differences. 599 
Many of the features described in the EC-KO mice including vascular dysfunction, arterial 600 
remodeling, aortic stiffness and aging are typically associated with oxidative stress and 601 
increased activation of Noxs as demonstrated in various models of cardiovascular disease [42].602 
Our findings here of increased NADPH-mediated O2- production support this notion and 603 
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suggest that EC Nox activity may be increased in EC-KO mice. Putative mechanisms whereby 604 
ERCC1 deficiency influences Noxs remain unclear and warrant further investigation. Reasons 605 
why there were no changes in global levels of O2- and H2O2 in EC-KO mice are unclear but 606 
may reflect efficient global antioxidant capacity.607 
As highlighted previously, vascular aging and DNA damage response are closely associated, 608 
as indicated by various research strategies from animal experiments to human (genetic) 609 
epidemiological studies and observations in progeroid syndromes [4,11,43]. In Mendelian 610 
randomization studies it was found that telomere length, an important marker of genomic 611 
instability, plays a causal role in CVD [44]. Epidemiologic research in large populations linking 612 
DNA damage response markers specifically obtained from circulating endothelial cells to 613 
various degrees of vascular dysfunction, eg. of vascular stiffness as measured by PWV, might 614 
provide important further evidence of the role of DNA damage in vascular aging. 615 
Epidemiological studies might also represent a future translational step of our findings as it 616 
could lead to development of markers that represent vascular age, which are potential tools for 617 
CVD risk prediction. Important in light of using endothelial cells for such marker studies is our618 
observation that the effect of DNA damage on NO signaling is specifically evoked within the619 
endothelium, possibly even cell-autonomously. Endothelium-specific markers might be an620 
important addition to biomarker testing, such as inflammatory markers and telomere length, in621 
white blood cells or in plasma, currently done in epidemiological studies that address vascular622 
age and CVD risk [44]. Whether this concerns only endothelial DNA damage response markers623 
or also inflammatory markers, is an important question. A limitation of our study is that we624 
were unable to explore mRNA of inflammatory factors specifically in the endothelium625 
(isolation of EC or their RNA was technically not feasible, data not shown). We cannot,626 
however, exclude the possibility that due to cell-autonomous effects ECs may assume a pro-627 
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inflammatory phenotype. Increased vascular leakage is suggestive of this and warrants further628 
exploration.629 
Despite cell autonomous effects on NO signaling, changes in EC-KO were not restricted to 630 
endothelial function alone, as witnessed by hypertrophic vascular remodeling in aorta, changes631 
in constrictions, but also the renal changes. EC-KO share some features with Ercc1ǻ- mice, 632 
including a worsened renal morphology and a shortened lifespan [45]. In an earlier publication 633 
rescuing the liver of Ercc1 null mutant mice from genetic Ercc1 inactivation, it was shown that 634 
next to the liver the renal tissue is exceptionally vulnerable to loss of Ercc1 function, and it was 635 
suggested that renal problems might be an important cause of death in the ‘rescued’ mice [46].636 
Our present results indicate that endothelial DNA damage might contribute to the renal 637 
problems.638 
Another important feature of aging is increased blood pressure. This appeared in EC-KO at 3 639 
months of age, but was absent at 5 months. We observed clues that at 5 months stroke volume 640 
and cardiac output were adapted in EC-KO, possibly to normalize blood pressure in a phase 641 
state during which widespread overt vasodilator dysfunction can be found. This might not have 642 
happened at 3 months of age since vasodilator function is not as widespread at that age. In 643 
earlier studies we observed a small increase of blood pressure in Ercc1ǻ/- mice. Apparently, the 644 
loss of endothelium-derived NO can be corrected, eg. by autonomic regulation.645 
In conclusion, we found that local endothelial genomic instability in mice reproduces important 646 
features of vascular aging that are also observed in humans. Increased vascular stiffness, 647 
vascular hypertrophic remodeling, loss of endothelium-dependent vasodilation, increased 648 
vascular leakage, and the differential vulnerability of various arteries are amongst the most 649 
important characteristics. Our present study adds to the growing evidence that the DNA 650 
damage response plays a central role in vascular aging, and that aging pathology can be driven 651 
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by genome instability and persistent DNA damage in a cell-autonomous manner in a variety of 652 
organs and tissues [47-51]. We propose epidemiological studies employing DNA damage 653 
response markers to further address the relevance in humans and provide a translational step 654 
towards CVD prediction markers. The loss of endothelium-derived NO and increased O2-655 
bioavailability might play a major role in the observed phenotype. Further, we have shown that 656 
diet restriction is another potential treatment option, as this rescues loss of vasodilator function 657 
in Ercc1ǻ- mice as well as in humans [8,12,52]. Therefore, studies exploring the impact of 658 
dietary restriction on DNA damage-induced vascular aging and the involved rescue 659 
mechanisms can be of great value.660 
661 
662 
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Clinical Perspectives663 
x Why was this study was undertaken? 664 
We wanted to know if endothelial DNA damage causes features of vascular aging. 665 
 666 
x Brief summary of the results 667 
We showed that endothelial DNA damage decreases endothelial-dependent vasodilations 668 
and end organ perfusion (lung and skin), increased vascular stiffness, vascular leakage 669 
(kidney) and wall thickness. The NO signaling pathway is specifically decreased. Superoxide 670 
formation, probably arising from NADPH oxidase, and possibly also cellular senescence 671 
might play a role in the observed aging features. 672 
 673 
x What is the potential significance of the results to human health and disease?674 
The observation that the vascular changes are associated with p21 increase is 675 
clinically relevant considering the development of senolytic drugs. The decreased NO,676 
and increased superoxides, is important for the clinical development of drugs acting 677 
on these pathways, eg. sGC activators and stimulators, PDE inhibitors, and Nox 678 
inhibitors.679 
Similar to human aging, arteries are differentially affected in mice lacking endothelial 680 
DNA repair. The coronary artery is the most rapidly affected vascular bed in our study 681 
and may have implications for coronary disease.682 
Renal vascular leakage and necrosis were observed, which might have implications 683 
for aging-related renal dysfunction. Our findings further support the use of p21 as a 684 
clinical biomarker for kidney injury.  685 
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Microvascular function is disturbed by the endothelial DNA repair defect and may 686 
have impact on aging-associated end organ dysfunction.687 
Future clinical studies on DNA damage and repair in the human vascular system are 688 
warranted. In particular, epidemiologic biomarker research specifically in endothelial 689 
cells might provide further evidence of the role of DNA damage and repair in CVD, 690 
and might be of additional value when optimizing CVD risk prediction691 
692 
693 
694 
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Table 1. Cardiac function, blood pressure and aorta distensibility at 3 and 5 months.919 
Parameter
3 months 5 months
EC-KO 
(n=10-19)
WT (n=11-
21)
p-
value
EC-KO 
(n=11-17)
WT (n=12-
31)
p-value
Stroke volume (uL) 33 (5.5) 36 (5.1) 0.21a 32 (8.0) 36 (5.0) 0.01a
Stroke volume  
index (uL/mg 
myocardium)*
30 (4.5) 31 (4.1) 0.56b 25 (5.2) 30 (3.5) 0.03b
Stroke volume  
index (uL/g)$
1.4 (0.2) 1.4 (0.2) 0.81b 1.2 (0.2) 1.3 (0.2) 0.49b
Fractional 
shortening (%)
34 (5.1) 34 (5.7) 0.71b 33 (6.5) 33 (6.0) 0.94b
HR (bpm)
502
(37.4)
492 (37.0) 0.38b
494
(40.1)
498 (49.2) 0.78b
Cardiac output 
(ml/min)
17 (2.9) 18 (3.3) 0.24a 16 (4.1) 18 (3.6) 0.01a
Cardiac Index 
(ml/min/mg 
myocardium)*
15 (2.3) 15 (2.6) 0.92b 13 (2.4) 14 (1.7) 0.06b
Cardiac Index 
(ml/min/g) $
0.7 (0.1) 0.7 (0.1) 0.93b 0.6 (0.1) 0.6 (0.1) 0.46b
Heart weight (mg)
112
(12.8)
116 (17.1) 0.45b
125
(25.3)
122 (20.2) 0.77b
SBP (mmHg)
138
(14.6)
125 (11.9) 0.04b
128
(22.8)
125 (20.6) 0.72b
DBP (mmHg) 94 (15.2) 89 (15.6) 0.46b 88 (19.3) 86 (20.7) 0.86b
Aorta distensibility 
(mm)
0.3 (0.1) 0.3 (0.04) 0.69b 0.2 (0.1) 0.3 (0.1) 0.05b
Values are Mean (SD). HR, heart rate; bpm, beats per minute; SBP, systolic blood pressure; DBP, 920 
diastolic blood pressure. * Values are corrected for heart weight, expressed as per 100 mg of heart 921 
weight. $ Values are corrected for body weight, expressed as per gram of body weight. a Two-way 922 
ANNOVA. bt-test.923 
924 
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Figure legends925 
Figure 1. General health and pathology findings. Body weights at 5 months (n= 9 EC-KO,926 
4 males and 5 females, and 37 WT, 19 males and 18 females) (A). Mason’s trichrome staining 927 
of kidney sections from a control mouse (B) and a EC-KO mouse (C) The area encircled shows 928 
extravasation of red blood cells in the proximity of the tubules. Kidney sections from 5 EC-929 
KO and 6 WT mice were examined. (D) Renal Evans Blue leakage (ug Evans Blue × mg of 930 
kidney tissue) 24 hours after intravenous injection, results are expressed as means ± SE, * p-931 
YDOXHFRPSDUHGWR:7JURXS932 
Figure 2. In vivo vasodilator function was assessed using Laser Doppler perfusion933 
imaging. Functional differences between skin reperfusion after 2 minutes of occlusion between 934 
WT (A) and EC-KO (B) at 3 months; and between WT (C) and EC-KO (D) at 5 months. 935 
Calculated area under the curve (E), and average maximum response (F) for the observed 936 
differences in skin reperfusion. * = p < 0.05 (t test EC-KO vs WT). At 3 months, 10 EC-KO 937 
and 20 WT mice were examined. At 5 months 13 EC-KO and 36 WT mice were examined.938 
Figure 3. μCT-based contrast-aided perfusion. μCT-based contrast images of WT and EC-939 
KO lungs (A). μCT-based contrast-aided perfusion images of WT and EC-KO lungs, 940 
showing average intensity of perfusion after subtraction of the contrast to non-contrast 941 
images as the color bar indicates (B). Scatter plots depicting average intensity as a measure 942 
for lung perfusion, which is significantly reduced in EC-KO compared to WT. * = p < 0.05 (t943 
test EC-KO vs WT) (C). 7 EC-KO and 4 WT mice were included for these measurements.944 
Figure 4. Endothelium-dependent and independent relaxations in isolated aortic and 945 
iliac rings measured ex vivo in organ bath set-ups. ACh-induced vasodilation of EC-KO946 
and WT in aorta and iliac artery at 3 months (A), and at 5 months (B). Endothelial-947 
independent relaxations induced by SNP in aortic and iliac rings at 3 months (C) and at 5 948 
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months (D). ** = p<0.001; *** = p<0.0001 (general linear model for repeated measures, 949 
sphericity assumed; EC-KO- aorta vs WT-aorta and EC-KO- iliac vs WT-iliac). At 3 months 950 
arteries from 9-12 EC-KO and 12-15 WT were studied. At 5 months arteries from 7-11 EC-951 
KO and 21-30 WT were studied.952 
Figure 5. Contribution of NO, prostaglandins and oxidative stress to the endothelium-953 
dependent vasodilations.  At 5 months we evaluated the contribution of NO and 954 
prostaglandins to ACh-induced vasodilation in WT (A) and EC-KO (B).  Vasodilator 955 
response in the presence of the wide range free radical scavengers (NAC) (C) and the H2O2956 
scavenger PEG-catalase in EC-KO mice (D). (E) Superoxide levels measured in lung tissue. 957 
(F) aortic stress-strain relationship measured ex vivo in small wire organ bath set up. The 958 
strain range corresponding to 80 – 120 mmHg pressure is indicated with the horizontal range 959 
bar. *** = p<0.0001 (general linear model for repeated measures, sphericity assumed; the 960 
responses to ACh alone were compared to the responses to ACh after preincubation with L-961 
NAME). Aorta arteries from 7-12 EC-KO and 21-28 WT were studied.962 
Figure 6. Vasodilation in coronary arteries measured ex vivo in small wire organ bath 963 
set-ups. 5HOD[DWLRQVWR$&K$613LQGXFHGYDVRGLODWDWLRQ%$'3ȕ6&DQG873Ȗ6964 
'LQFRURQDU\ULQJVSUHFRQVWULFWHGZLWK85HOD[DWLRQVWR$'3ȕ6(DQG873Ȗ6)965 
in coronary rings preconstricted with KCl 30mM. *** = p<0.0001 (GLM-RM, EC-KO- 3966 
months vs WT- 3 months and EC-KO- 5 months vs WT- 5 months). At 3 months coronary 967 
arteries from 7 EC-KO and 8-9 WT were studied. At 5 months arteries from 7 EC-KO and 10 968 
WT were studied.969 
Figure 7. Levels of eNOS and scanning electron microscopy. Protein expression levels970 
expressed as % of WT control in lung of (A) eNOS and p-eNOS over actin (n=5 EC-KO and 971 
6 WT), (B) Representative scanning electron microscopy images of the endothelium (n=5 EC-972 
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KO and 5 WT), and (C) expression of ERCC1 (arrowhead) (n=4 for both WT and EC-KO). *: 973 
p<0.05, t-test. (D) Representative blot of ERCC1.974 
Figure 8. Aortic wall dimensions. All measurements were performed on eosin-stained 975 
cryosections at 50x magnification using calibrated QWin software (Leica, Germany). Panel A 976 
– F depict the various dimension variables as indicated above the panels. ‘Internal’ and 977 
‘External’ refer to the use of respectively the internal and external border of the lamina media978 
as reference points for the measurements. *; p < 0.05, t-test.979 
Figure 9. P21 staining. Photographs A through C show p21 staining in aortic tissue of EC-980 
KO (A) and WT (B). The endothelial localization is evident at 40 x magnification (closed 981 
arrowheads), and at larger magnification (80 x) the nuclear localization of p21 is visible 982 
(Panel A, open arrowhead). The p21-positive cell in panel A display the typical cobblestone 983 
appearance and localization on the lamina elastica interna (L.E.I), identifying the positive 984 
cells as endothelial cells. WT show p21-negative endothelial cell nuclei (B, grey arrowhead). 985 
Photographs C through E show p21 staining in the kidney in EC-KO (C,D) and WT (E). p21-986 
positive cells are present along vascular lumen (closed arrowheads), along tubuli (grey 987 
arrowheads) and in glomeruli (gl; open arrowheads) (panel C). Panel D shows positive cells 988 
along the lumen of the vessel wall at higher magnification. WT mice did not present positive 989 
cells (panel E). Asterisks mark vascular lumen. 990 
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